CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents Impact of Staging Percutaneous Coronary Intervention in Left Main Artery Disease: Insights From the EXCEL Trial Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI Optimal threshold of postintervention minimum stent area to predict in-stent restenosis in small coronary arteries: An optical coherence tomography analysis Global Approach to High Bleeding Risk Patients With Polymer-Free Drug-Coated Coronary Stents: The LF II Study Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial Right ventricular expression of NT-proBNP adds predictive value to REVEAL score in patients with pulmonary arterial hypertension High-Resolution Cardiac Magnetic Resonance Imaging Techniques for the Identification of Coronary Microvascular Dysfunction

Clinical Trial2014 Dec 4;371(23):2155-66

JOURNAL:N Engl J Med. Article Link

Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents

Mauri L, Kereiakes DJ, DAPT Study Investigators. Keywords: DAPT duration; coronary artery disease; DES; platelet aggregation; inhibitors; stents; thrombosis

FULL TEXT PDF